Your browser doesn't support javascript.
loading
Clinical performance of a novel hybrid IVUS-OCT system: a multicentre, randomised, non-inferiority trial (PANOVISION).
Jia, Haibo; Zhao, Chen; Yu, Huai; Wang, Zhao; Liu, Huimin; Xu, Maoen; Hu, Sining; Li, Lulu; He, Luping; Weng, Ziqian; Qin, Yuhan; Xu, Yishuo; Zeng, Ming; Su, Xi; Liu, Bin; Hou, Jingbo; Yu, Bo.
Afiliação
  • Jia H; Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
  • Zhao C; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, People's Republic of China.
  • Yu H; Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
  • Wang Z; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, People's Republic of China.
  • Liu H; Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
  • Xu M; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, People's Republic of China.
  • Hu S; School of Electronic Science and Engineering, University of Electronic Science and Technology of China, Chengdu, People's Republic of China.
  • Li L; Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
  • He L; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, People's Republic of China.
  • Weng Z; Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
  • Qin Y; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, People's Republic of China.
  • Xu Y; Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
  • Zeng M; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, People's Republic of China.
  • Su X; Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
  • Liu B; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, People's Republic of China.
  • Hou J; Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
  • Yu B; The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, People's Republic of China.
EuroIntervention ; 19(4): e318-e320, 2023 07 17.
Article em En | MEDLINE | ID: mdl-37057604
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Stents Farmacológicos Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Stents Farmacológicos Idioma: En Ano de publicação: 2023 Tipo de documento: Article